Cargando…

Selective Elevation of Antibodies to Desmoglein 1 during the Transition from Mucocutaneous to Cutaneous Type Pemphigus Vulgaris

Detalles Bibliográficos
Autores principales:	Matsuda-Hirose, Haruna, Ishikawa, Kazushi, Goto, Mizuki, Hatano, Yutaka, Fujiwara, Sakuhei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Dermatological Association; The Korean Society for Investigative Dermatology 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662933/ https://www.ncbi.nlm.nih.gov/pubmed/23717031 http://dx.doi.org/10.5021/ad.2013.25.2.263

Ejemplares similares

Desmogleins 1, 3, and E-cadherin immunohistochemical expression within mucocutaneous pemphigus vulgaris
por: Alshami, Muhanad Lebnan, et al.
Publicado: (2022)

Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris
por: Amber, Kyle T., et al.
Publicado: (2018)

Autoantibodies other than Anti-desmogleins in Pemphigus Vulgaris Patients
por: Saleh, Marwah Adly, et al.
Publicado: (2017)

Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris
por: Di Lullo, Giulia, et al.
Publicado: (2019)

Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous
por: Lucchese, Alberta, et al.
Publicado: (2006)

Long-lasting Localized Pemphigus Vulgaris without Detectable Serum Autoantibodies Against Desmoglein 3 and Desmoglein 1
por: Yoshifuku, Asuka, et al.
Publicado: (2016)

Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris
por: Koch, Peter J., et al.
Publicado: (1997)

Do serum prolactin levels correlate with antibodies against desmoglein in pemphigus vulgaris?
por: Iraji, Fariba, et al.
Publicado: (2016)

Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity
por: Delavarian, Zahra, et al.
Publicado: (2020)

Successful Treatment of Pemphigus Vulgaris With the Extensive Mucocutaneous Lesions in an Elderly Patient
por: Masjedi, Mohsen, et al.
Publicado: (2014)

Acantholysis may precede elevation of circulating anti‐desmoglein 3 antibody levels in pemphigus vulgaris presenting with desquamative gingivitis
por: Endo, Hiroyasu, et al.
Publicado: (2019)

Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes
Publicado: (1993)

An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris
por: Schulze, Katja, et al.
Publicado: (2011)

Improving Treatment Outcome of Pemphigus Vulgaris on Vietnamese Patients by Using Desmoglein Elisa Test
por: Van, Anh Tran Thi, et al.
Publicado: (2019)

Pathogenic activity of circulating anti-desmoglein-3 autoantibodies isolated from pemphigus vulgaris patients
por: Narbutt, Joanna, et al.
Publicado: (2012)

HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies
por: Lakoš Jukić, Ines, et al.
Publicado: (2023)

Generation of an anti-desmoglein 3 antibody without pathogenic activity of pemphigus vulgaris for therapeutic application to squamous cell carcinoma
por: Funahashi, Shin-Ichi, et al.
Publicado: (2018)

Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris
por: Schlögl, Elisabeth, et al.
Publicado: (2018)

A New Solid-Phase Immunosorbent for Selective Binding of Desmoglein 3 Autoantibodies in Patients with Pemphigus Vulgaris
por: Abramova, T. V., et al.
Publicado: (2020)

Plakophilins, desmogleins, and pemphigus: the tail wagging the dog
por: Ellebrecht, Christoph T., et al.
Publicado: (2014)

Autoantibodies against desmoglein 2 are not pathogenic in pemphigus()
por: Miguel, Marcela Calixto Brandão, et al.
Publicado: (2022)

Desmoglein compensation hypothesis fidelity assessment in Pemphigus
por: Sielski, Lauren, et al.
Publicado: (2022)

Subtype transition from pemphigus vulgaris to pemphigus foliaceus
por: Gilkey, Ty, et al.
Publicado: (2022)

A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
por: Lotti, Roberta, et al.
Publicado: (2023)

Salivary Desmoglein Enzyme-Linked Immunosorbent Assay for Diagnosis of Pemphigus Vulgaris: A Noninvasive Alternative Test to Serum Assessment
por: Mortazavi, Hossein, et al.
Publicado: (2015)

Loss of flotillin expression results in weakened desmosomal adhesion and Pemphigus vulgaris-like localisation of desmoglein-3 in human keratinocytes
por: Völlner, Frauke, et al.
Publicado: (2016)

Anti-Thyroid Peroxidase Reactivity Is Heightened in Pemphigus Vulgaris and Is Driven by Human Leukocyte Antigen Status and the Absence of Desmoglein Reactivity
por: Seiffert-Sinha, Kristina, et al.
Publicado: (2018)

A randomised clinical trial to assess the adjuvant potential of methotrexate to corticosteroids in mucosal or limited mucocutaneous pemphigus vulgaris
por: Jain, Khimit, et al.
Publicado: (2022)

Autoantibodies against Desmoglein 1 and 3 in South Tunisian pemphigus
por: Jerbi, Ameni, et al.
Publicado: (2021)

Is transition between subtypes of pemphigus possible? A series of pemphigus vulgaris patients showing the transition to pemphigus foliaceus()
por: Kucukoglu, Rifkiye, et al.
Publicado: (2023)

FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus
por: Maho-Vaillant, Maud, et al.
Publicado: (2022)

Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice
por: Hofrichter, Maxi, et al.
Publicado: (2018)

Pemphigus vulgaris
por: Tamgadge, Sandhya, et al.
Publicado: (2011)

Pemphigus vulgaris
por: Porro, Adriana Maria, et al.
Publicado: (2019)

Transition from Pemphigus Foliaceus to Pemphigus Vulgaris: Case Report with Literature Review
por: Park, Sang Gun, et al.
Publicado: (2006)

Dermatoscopy in Diagnosis of Cutaneous Myiasis Arising in Pemphigus Vulgaris Lesions
por: Vinay, Keshavamurthy, et al.
Publicado: (2017)

Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6- associated Pemphigus vulgaris
por: Tong, Joo Chuan, et al.
Publicado: (2006)

Intracellular domain of desmoglein 3 (pemphigus vulgaris antigen) confers adhesive function on the extracellular domain of E-cadherin without binding catenins
Publicado: (1995)

Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
por: Rehman, Ambreen, et al.
Publicado: (2021)

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
por: BOCH, Katharina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_259pptd7mmno2eire6qkho52nb